[SECONDARY PREVENTION OF ARTERIAL HYPERTENSION IN VEHICLE DRIVERS--EFFICIENCY, SPECIFIC SAFETY].

Aim: To estimate effectiveness and safety of pharmacotherapy in vehicle drivers with arterial hypertension (AH).

Materials And Methods: 432 patients with grade I-III AH including 82 with cardiovascular complications largely of II and III grade were under observation during 2.5-4 months using clinical and instrumental methods (24hr AP & ECG monitoring) as well as psychophysiological testing (PPT).

[Isradipine in arterial hypertension in motor vehicle drivers].

The study covered influence of Isradipine (2.5 mg administered twice daily during 6 weeks) on blood circulation in the heart and occupationally important functions and traits among 30 drivers having mild and moderate arterial hypertension (AH). Systolic and diastolic pressure demonstrate reliable decrease in all the examinees with mild AH and in 93.

[Cardiovascular diseases in motor vehicle drivers and traffic safety].

Epidemiologic, electrophysiologic and psychophysiologic studies among urban and rural automobile drivers helped to reveal occurrence of coronary artery disease (CAD), arterial hypertension (AH) and their risk factors. In addition, special studies (monitoring of ECG in natural conditions) among 118 drivers diagnosed the signs of coronary failure and arrhythmias. Psychophysiologic studies among the individuals suffering from cardiovascular diseases (CAD, AH and arrhythmias) proved worse parameters important for occupational activities and for traffic safety.